赛马林4A通过激活由PlexinB1介导的NF-κB通路来促进肺癌
Xiang Wei1, Zhili Liu2, Yili Shen1
1Department of Respiratory Medicine, Huzhou Central Hospital, Affiliated Central Hospital, Huzhou University, Huzhou, Zhejiang, China.
PeerJ
|October 30, 2023
概括
赛马林4A (Sema4A) 通过通过PlexinB1.1.激活NF-κB通路来促进肺癌 (LC) 的生长. 向Sema4A为肺癌提供了一个潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 肺癌 (LC) 是一种普遍存在的恶性瘤,预后不佳.
- 赛马林4A (Sema4A) 在各种生理和病理过程中发挥作用.
- 塞马4A在LC发育和进展中的特定作用需要进一步阐明.
研究的目的:
- 调查Sema4A在肺癌 (LC) 中的作用.
- 探索Sema4A影响LC进展的潜在分子机制.
- 评估Sema4A作为LC治疗标的潜力.
主要方法:
- 在LC细胞系和组织中分析了Sema4A表达.
- 细胞被操纵 (siRNA,蛋白质治疗) 并用阻断抗体和途径抑制剂刺激.
- 细胞的增殖,迁移,入侵和活力都使用标准测试进行了评估.
- 关键信号通路蛋白质 (NF-κB,Stat3,MAPK) 和细胞因子 (IL-6) 的分泌量得到量化.
主要成果:
- 在LC组织和细胞中Sema4A的表达很高,激活NF-κB通路并调节PlexinB1mRNA.
- Sema4A knockdown抑制了LC细胞功能,而Sema4A-Fc蛋白质的使用则逆转了这些效应.
- 阻断plexinB1的抗体抑制了Sema4A诱导的细胞功能和NF-κB通路的激活.
- 塞马4A促进了IL-6的产生,这种IL-6通过PlexinB1阻断和NF-κB抑制而减少.
结论:
- 塞马4A通过激活NF-κB通路来促进LC的发展,这种通路可能由PlexinB1.1介导.
- 这些发现将Sema4A确定为肺癌治疗的潜在治疗标.
- 准Sema4A/PlexinB1/NF-κB轴可能为治疗肺癌提供一种新的策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K


